We just received data on a new analyst forecast for $CRMD. Brandon Folkes from HC Wainwright & Co. set a price target of 13.0 for CRMD.
To track analyst ratings and price targets for $CRMD, check out Quiver Quantitative's $CRMD forecast page.
Should you buy $CRMD?
Some analysts are better than others. To view the past performance of HC Wainwright & Co., check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CRMD Price Targets
Multiple analysts have issued price targets for $CRMD recently. We have seen 5 analysts offer price targets for $CRMD in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- Brandon Folkes from HC Wainwright & Co. set a target price of $13.0 on 01/23/2026
- Leonid Timashev from RBC Capital set a target price of $13.0 on 01/21/2026
- Jason Kolbert from D. Boral Capital set a target price of $14.0 on 01/08/2026
- Serge Belanger from Needham set a target price of $15.0 on 01/08/2026
- Jason N. Butler from JMP Securities set a target price of $22.0 on 09/09/2025
$CRMD Insider Trading Activity
$CRMD insiders have traded $CRMD stock on the open market 15 times in the past 6 months. Of those trades, 1 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $CRMD stock by insiders over the last 6 months:
- JANET DILLIONE has made 0 purchases and 5 sales selling 147,000 shares for an estimated $1,547,555.
- JOSEPH TODISCO (Chief Executive Officer) has made 0 purchases and 2 sales selling 80,000 shares for an estimated $1,010,000.
- ELIZABETH HURLBURT (Chief Operating Officer) has made 0 purchases and 2 sales selling 53,997 shares for an estimated $711,817.
- KAUFMAN BETH ZELNICK (Chief Legal Officer) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $670,264.
- STEVEN W LEFKOWITZ sold 40,000 shares for an estimated $475,200
- ALAN W DUNTON has made 0 purchases and 2 sales selling 30,000 shares for an estimated $391,300.
- MYRON KAPLAN purchased 25,000 shares for an estimated $275,500
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRMD Revenue
$CRMD had revenues of $104.3M in Q3 2025. This is an increase of 810.22% from the same period in the prior year.
You can track CRMD financials on Quiver Quantitative's CRMD stock page.
$CRMD Hedge Fund Activity
We have seen 144 institutional investors add shares of $CRMD stock to their portfolio, and 62 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. added 3,323,833 shares (+inf%) to their portfolio in Q3 2025, for an estimated $38,656,177
- MARSHALL WACE, LLP added 893,518 shares (+34.6%) to their portfolio in Q3 2025, for an estimated $10,391,614
- UBS GROUP AG added 814,964 shares (+295.3%) to their portfolio in Q3 2025, for an estimated $9,478,031
- JUMP FINANCIAL, LLC added 774,083 shares (+inf%) to their portfolio in Q3 2025, for an estimated $9,002,585
- NUVEEN, LLC removed 772,997 shares (-52.6%) from their portfolio in Q3 2025, for an estimated $8,989,955
- GHISALLO CAPITAL MANAGEMENT LLC removed 750,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,722,500
- ANSON FUNDS MANAGEMENT LP removed 725,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,431,750
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
